Neurocrine Biosciences

reshuffle pipeline target reorganize shift change
Biotech

Neurocrine pens $880M pact with TransThera for immunology target

San Diego-based Neurocrine secured the rights to develop and commercialize preclinical NLRP3 inhibitors.
James Waldron Nov 3, 2025 5:42am
Alps parachute rainbow mountains

Sanofi vaccine vet vaults to GSK—Chutes & Ladders

Jun 13, 2025 8:30am
ship offload depart tugboat boat

Neurocrine hands back 2 CNS gene therapy programs to Voyager

May 7, 2025 7:30am
Paraglider over a snowy mountain

J&J innovator vaults to Valo—Chutes & Ladders

Apr 11, 2025 8:30am
Three blocks displaying from left to right a person a handshake and another person

Harbour spinoff pens $395M deal for preclinical Crenessity rival

Feb 26, 2025 5:14am
skydiving mountain parachute

Takeda taps Julie Kim as new CEO—Chutes & Ladders

Jan 31, 2025 8:30am